NOV 20, 2018 3:43 PM PST

Survival of the SCID Patient

WRITTEN BY: Nicholas Breehl

A recent study highlights the effectiveness of treatments provided to patients of severe combined immunodeficiency (SCID). The study reveals a relationship between the genotype of the patients SCID and the efficacy of a stem cell transplant in regards to immune system reconstitution and survival rates. The study’s lead researcher is a pediatric immunologist at CHU Sainte-Justine and professor at Université de Montréal, Dr. Elie Haddad.

Severe combined immunodeficiency or SCID is an inherited immune system disorder characterized by abnormalities with responses of both T cells and B cells – the white blood cells needed for immune system function). Common signs and symptoms include increased susceptibility to infections including ear infections; pneumonia or bronchitis; oral thrush; and diarrhea.

SCID may be caused by mutations in any of several genes and can be inherited in an X-linked recessive (most commonly) or autosomal recessive manner. The most common type of SCID is the X-linked severe combined immunodeficiency (XSCID).

The study was international and included the medical history of more than 600 patients ranging from 1982-2012 in over 30 different centers. The study published in Blood incorporated those SCID individuals that received a hematopoietic stem cell transplant as their therapy.

"Immune diseases are among the top priorities at CHU Sainte-Justine in terms of care, teaching, and research," Haddad said. "There are only one or two cases of SCID per year in Quebec. Having access to such a cohort of patients with this rare disease and over such a long period has provided us with significant and unique data to advance our knowledge in this area."

After reviewing the data, the results describe survival rates of patients who receive stem cell transplants from related donors are most successful. While around 86 percent of patients who undergo stem cell transplants are from non-related donors and the success of their therapy is strongly impacted by the genotype of the patient.

Interestingly, the data show the lower the age of the patient and the absence of infection during therapy increased the success of the transplant and the longevity of the patient thereafter.

"We need to develop patient-specific treatment strategies," Haddad said. "There is a critical need for neonatal screening to establish appropriate isolation, implement infection-prevention measures, particularly before transplantation, and ensure rapid referral for bone-marrow transplant or gene therapy after diagnosis."

"In our future research, our objective will be to analyze the late effects of conditioning and the quality of long-term immune-system reconstitution after hematopoietic cell transplant for this deficiency," said Haddad. Finally, the scientists remark, “Our data emphasize the need for patient-tailored treatment strategies depending upon the underlying SCID genotype.”

Sources: Blood, Science Daily, NIH, YouTube

About the Author
You May Also Like
NOV 13, 2019
Health & Medicine
NOV 13, 2019
Antibiotic Resistance by the Numbers
The Centers for Disease Control and Prevention (CDC) just released its latest Antibiotic Threats in the United States report, which is summarized in the vi...
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Drug Targets Against The Nipah Virus
The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infect...
JAN 04, 2020
Immunology
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inf...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
FEB 23, 2020
Immunology
FEB 23, 2020
New discovery could help preterm babies breathe easy
Babies born more than three weeks before full term are met with complicated and often life-threatening health challenges. Most notably, these tiny preterm...
Loading Comments...